FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989215620> ?p ?o ?g. }

• W1989215620 endingPage "2150" @default.
• W1989215620 startingPage "2140" @default.
• W1989215620 abstract "Despite the discovery of potent GH-releasing peptides (GHRPs) more than 15 yr ago and the recent cloning of human, rat, and pig GHRP receptors in the hypothalamus and pituitary gland, the neuroregulatory mechanisms of action of GHRP agonists on the human hypothalamo-somatotroph unit are not well delineated. To gain such clinical insights, we evaluated the ultradian (pulsatile), entropic (pattern orderliness), and nyctohemeral GH secretory responses during continuous 24-h i.v. infusion of saline vs. the most potent clinically available hexapeptide, GHRP-2 (1 microg/kg x h) in estrogen-unreplaced (mean serum estradiol, 12 +/- 2.4 pg/mL) postmenopausal women (n = 7) in a paired, randomized design. Blood was sampled every 10 min for 24 h during infusions and was assayed by ultrasensitive GH chemiluminescence assay. Pulsatile GH secretion was quantitated by deconvolution analysis, orderliness of GH release patterns by the approximate entropy statistic, and 24-h GH rhythmicity by cosinor analysis. Statistical analysis revealed that GHRP-2 elicited a 7.7-fold increase in (24-h) mean serum (+/-SEM) GH concentrations, viz. from 0.32 +/- 0.042 (saline) to 2.4 +/- 0.34 microg/L (GHRP-2; P = 0.0006). This occurred via markedly stimulated pulsatile GH release, namely a 7.1-fold augmentation of GH secretory burst mass: 0.87 +/- 0.18 (control) vs. 6.3 +/- 1.3 microg/L (GHRP-2; P = 0.0038). Enhanced GH pulse mass reflected a commensurate 10-fold (P = 0.023) rise in GH secretory burst amplitude [maximal GH secretory rate (micrograms per L/min) attained within a secretory pulse] with no prolongation in event duration. GH burst frequency, interpulse interval, and calculated GH half-life were all invariant of GHRP-2 treatment. Concurrently, as detected in the ultrasensitive GH assay, GHRP-2 augmented deconvolution-estimated interpulse (basal) GH secretion by 4.5-fold (P = 0.025). The approximate entropy of 24-h serum GH concentration profiles rose significantly during GHRP-2 infusion; i.e. from 0.592 +/- 0.073 (saline) to 0.824 +/- 0.074 (GHRP-2; P = 0.0011), signifying more irregular or disorderly GH release patterns during secretagogue stimulation. Cosinor analysis of 24-h GH rhythms disclosed a significantly earlier (daytime) acrophase at 2138 h (+/- 140 min) during GHRP-2 stimulation vs. 0457 h (+/-42 min) during saline infusion (P = 0.013). Concomitantly, the cosinor amplitude rose 6-fold (P = 0.018), and the mesor (cosine mean) rose 5-fold (P = 0.003). Fasting (0800 h) plasma insulin-like growth factor (IGF-I) concentrations rose by -11 +/- 12 microg/L during saline infusion and by 102 +/- 18 microg/L during GHRP-2 infusion (P = 0.0036). GHRP-2 infusion did not modify (24-h pooled) serum LH, FSH, or TSH concentrations and minimally increased serum (pooled) daily PRL (6.8 +/- 0.83 vs. 12 +/- 1.2 microg/L; P < 0.05) and cortisol (5.3 +/- 0.59 to 7.0 +/- 0.74; P < 0.05) concentrations. In summary, 24-h constant iv GHRP-2 infusion in the gonadoprival female neurophysiologically activates the GH-IGF-I axis by potentiating GH secretory burst mass and amplitude by 7- to 10-fold and augmenting the basal (nonpulsatile) GH secretion by 4.5-fold. GHRP-2 action is highly selective, as it does not alter GH secretory burst frequency, interpulse interval, event duration, or GH half-life. GHRP-2 effectively elevates IGF-I concentrations, unleashes greater disorderliness of GH release patterns, and heightens the 24-h rhythmicity of GH secretion. These tripartite features of GHRP-2's action in estrogen-withdrawn (postmenopausal) women also characterize normal human puberty and/or sex steroid regulation of the GH-IGF-I axis. However, how or whether GHRP-2 interacts further with sex hormone modulation of GH neurosecretory control in older women and men is not yet known." @default.
• W1989215620 created "2016-06-24" @default.
• W1989215620 creator A5003698342 @default.
• W1989215620 creator A5004497797 @default.
• W1989215620 creator A5040403608 @default.
• W1989215620 creator A5050107950 @default.
• W1989215620 date "1999-06-01" @default.
• W1989215620 modified "2023-09-27" @default.
• W1989215620 title "Tripartite Neuroendocrine Activation of the Human Growth Hormone (GH) Axis in Women by Continuous 24-Hour GH-Releasing Peptide Infusion: Pulsatile, Entropic, and Nyctohemeral Mechanisms1" @default.
• W1989215620 cites W136683754 @default.
• W1989215620 cites W181028834 @default.
• W1989215620 cites W1970805105 @default.
• W1989215620 cites W1976170434 @default.
• W1989215620 cites W1976356327 @default.
• W1989215620 cites W1978628439 @default.
• W1989215620 cites W1981695760 @default.
• W1989215620 cites W1992400787 @default.
• W1989215620 cites W1993038559 @default.
• W1989215620 cites W1995734405 @default.
• W1989215620 cites W2002004921 @default.
• W1989215620 cites W2002748611 @default.
• W1989215620 cites W2005714662 @default.
• W1989215620 cites W2007971998 @default.
• W1989215620 cites W2014109469 @default.
• W1989215620 cites W2015174242 @default.
• W1989215620 cites W2021733510 @default.
• W1989215620 cites W2022761976 @default.
• W1989215620 cites W2030484442 @default.
• W1989215620 cites W2031098338 @default.
• W1989215620 cites W2038584436 @default.
• W1989215620 cites W2047074434 @default.
• W1989215620 cites W2047853675 @default.
• W1989215620 cites W2053242077 @default.
• W1989215620 cites W2054455773 @default.
• W1989215620 cites W2059057664 @default.
• W1989215620 cites W2061570084 @default.
• W1989215620 cites W2069214336 @default.
• W1989215620 cites W2094719820 @default.
• W1989215620 cites W2095439993 @default.
• W1989215620 cites W2102385712 @default.
• W1989215620 cites W2117138448 @default.
• W1989215620 cites W2117689856 @default.
• W1989215620 cites W2125784905 @default.
• W1989215620 cites W2127461774 @default.
• W1989215620 cites W2130453289 @default.
• W1989215620 cites W2134127282 @default.
• W1989215620 cites W2156478759 @default.
• W1989215620 cites W2158337337 @default.
• W1989215620 cites W2161623549 @default.
• W1989215620 cites W2164123954 @default.
• W1989215620 cites W2172188885 @default.
• W1989215620 cites W2175953586 @default.
• W1989215620 cites W2177373125 @default.
• W1989215620 cites W265859318 @default.
• W1989215620 cites W75839574 @default.
• W1989215620 cites W2552392369 @default.
• W1989215620 doi "https://doi.org/10.1210/jcem.84.6.5687" @default.
• W1989215620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10372723" @default.
• W1989215620 hasPublicationYear "1999" @default.
• W1989215620 type Work @default.
• W1989215620 sameAs 1989215620 @default.
• W1989215620 citedByCount "29" @default.
• W1989215620 countsByYear W19892156202014 @default.
• W1989215620 countsByYear W19892156202019 @default.
• W1989215620 crossrefType "journal-article" @default.
• W1989215620 hasAuthorship W1989215620A5003698342 @default.
• W1989215620 hasAuthorship W1989215620A5004497797 @default.
• W1989215620 hasAuthorship W1989215620A5040403608 @default.
• W1989215620 hasAuthorship W1989215620A5050107950 @default.
• W1989215620 hasBestOaLocation W19892156201 @default.
• W1989215620 hasConcept C121446783 @default.
• W1989215620 hasConcept C126322002 @default.
• W1989215620 hasConcept C134018914 @default.
• W1989215620 hasConcept C136792703 @default.
• W1989215620 hasConcept C185592680 @default.
• W1989215620 hasConcept C2777658017 @default.
• W1989215620 hasConcept C2781042741 @default.
• W1989215620 hasConcept C2984496839 @default.
• W1989215620 hasConcept C71315377 @default.
• W1989215620 hasConcept C71924100 @default.
• W1989215620 hasConcept C79191276 @default.
• W1989215620 hasConcept C86803240 @default.
• W1989215620 hasConcept C94984642 @default.
• W1989215620 hasConceptScore W1989215620C121446783 @default.
• W1989215620 hasConceptScore W1989215620C126322002 @default.
• W1989215620 hasConceptScore W1989215620C134018914 @default.
• W1989215620 hasConceptScore W1989215620C136792703 @default.
• W1989215620 hasConceptScore W1989215620C185592680 @default.
• W1989215620 hasConceptScore W1989215620C2777658017 @default.
• W1989215620 hasConceptScore W1989215620C2781042741 @default.
• W1989215620 hasConceptScore W1989215620C2984496839 @default.
• W1989215620 hasConceptScore W1989215620C71315377 @default.
• W1989215620 hasConceptScore W1989215620C71924100 @default.
• W1989215620 hasConceptScore W1989215620C79191276 @default.
• W1989215620 hasConceptScore W1989215620C86803240 @default.
• W1989215620 hasConceptScore W1989215620C94984642 @default.
• W1989215620 hasIssue "6" @default.
• W1989215620 hasLocation W19892156201 @default.

• next